US20030053970A1 - Deodorizing preparations - Google Patents

Deodorizing preparations Download PDF

Info

Publication number
US20030053970A1
US20030053970A1 US10/181,641 US18164102A US2003053970A1 US 20030053970 A1 US20030053970 A1 US 20030053970A1 US 18164102 A US18164102 A US 18164102A US 2003053970 A1 US2003053970 A1 US 2003053970A1
Authority
US
United States
Prior art keywords
acid
preparations
contain
weight
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/181,641
Other languages
English (en)
Inventor
Stefan Bruening
Helga Gondek
Achim Ansmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis IP Management GmbH
Original Assignee
Cognis Deutschland GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7628360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20030053970(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cognis Deutschland GmbH and Co KG filed Critical Cognis Deutschland GmbH and Co KG
Assigned to COGNIS DEUTSCHLAND GMBH & CO. KG reassignment COGNIS DEUTSCHLAND GMBH & CO. KG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ANSMANN, ACHIM, GONDEK, HELGA, BRUENING, STEFAN
Publication of US20030053970A1 publication Critical patent/US20030053970A1/en
Priority to US12/202,990 priority Critical patent/US8765104B2/en
Assigned to COGNIS IP MANAGEMENT GMBH reassignment COGNIS IP MANAGEMENT GMBH PATENT AND TRADEMARK TRANSFER AND LICENSE AGREEMENT Assignors: COGNIS DEUTSCHLAND GMBH & CO. KG
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Definitions

  • This invention relates to deodorizing preparations containing dialkyl carbonates, antiperspirants, esterase inhibitors, bactericidal or bacteriostatic agents and/or perspiration-absorbing substances and to their use for the production of deodorizing preparations.
  • deodorants are used to eliminate unpleasant body odors.
  • examples of such substances are aluminium compounds, such as aluminium sulfate or aluminium chlorhydrate, zinc salts and citric acid compounds. Since the problem of odor inhibition has by no means been completely solved, there is still a need for new preparations in which the deodorants can readily be emulsified and incorporated. This is intended to ensure more uniform distribution of the deodorants and, hence, an improvement in their effect, i.e. minimization of perspiration and a reduction in odor formation. In addition, the feeling of the skin after the application of deodorants should be improved and greater stability of the final formulations achieved in relation to the prior art.
  • the present invention relates to deodorizing preparations containing
  • R 1 is a linear alkyl and/or alkenyl group containing 6 to 22 carbon atoms, a 2-ethylhexyl, isotridecyl or isostearyl group or a group derived from a polyol containing 2 to 15 carbon atoms and at least two hydroxyl groups
  • R 2 has the same meaning as R 1 or is an alkyl group containing 1 to 5 carbon atoms and n and m independently of one another stand for 0 or numbers of 1 to 100,
  • Dialkyl carbonates which form component (a) are basically known compounds even through some of the claimed compounds are being described for the first time in the present specification. Basically, they may be prepared by transesterification of dimethyl or diethyl carbonate with the hydroxy compounds mentioned using known methods. A review of these methods can be found, for example, in Chem. Rev. 96, 951 (1996). Dialkyl carbonates corresponding to formula (I) which are particularly suitable for solving the stated problem satisfy one of the following requirements:
  • R 1 is a linear alkyl group containing 8 to 18 carbon atoms or a 2-ethylhexyl group and R 2 has the same meaning as R 1 or represents methyl;
  • R 1 is a linear alkyl group containing 12 to 18 carbon atoms
  • R 2 has the same meaning as R 1 or represents methyl and n and m stand for numbers of 1 to 10;
  • R 1 is a residue of a polyol selected from the group consisting of glycerol, alkylene glycols, technical oligoglycerol mixtures, methylol compounds, lower alkyl glucosides, sugar alcohols, sugars and aminosugars and R 2 has the same meaning as R 1 or represents a linear or branched alkyl group containing 8 to 12 carbon atoms or methyl.
  • dialkyl carbonates belonging to the two groups (A) and (B) are complete or partial transesterification products of dimethyl and/or diethyl carbonate with caproic alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmitoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and the technical mixtures thereof formed, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from Roelen's oxosynthesis and as monomer fraction in the
  • transesterification products of the lower carbonates with the alcohols mentioned in the form of their adducts with 1 to 100, preferably 2 to 50 and more preferably 5 to 20 moles of ethylene oxide are also suitable.
  • Di-n-octyl carbonates are preferred
  • the carbonates of group (C) are being described for the first time in the present specification. They are compounds which are obtained by complete or partial transesterification of dimethyl and/or diethyl carbonate with polyols. Polyols suitable for the purposes of the invention preferably contain 2 to 15 carbon atoms and at least two hydroxyl groups. Typical examples are
  • alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and also polyethylene glycols with an average molecular weight of 100 to 1,000 dalton;
  • methylol compounds such as, in particular, trimethylol ethane, trimethylol propane, trimethylol butane, pentaerythritol and dipentaerythritol;
  • lower alkyl glucosides more particularly those containing 1 to 8 carbon atoms in the alkyl group, for example methyl and butyl glucoside;
  • sugar alcohols containing 5 to 12 carbon atoms such as, for example, sorbitol or mannitol;
  • sugars containing 5 to 12 carbon atoms such as, for example, glucose or sucrose and
  • aminosugars such as, for example, glucamine.
  • the preparations according to the invention may contain the dialkyl carbonates in quantities of 1 to 80, preferably 5 to 50 and more particularly 10 to 30% by weight, based on the solids content.
  • the antiperspirants of component (b1) are salts of aluminium, zirconium or zinc.
  • Suitable antihydrotic agents of this type are, for example, aluminium chloride, aluminium chlorohydrate, aluminium dichlorohydrate, aluminium sesquichlorohydrate and complex compounds thereof, for example with 1,2-propylene glycol, aluminium hydroxyallantoinate, aluminium chloride tartrate, aluminium zirconium trichlorohydrate, aluminium zirconium tetrachlorohydrate, aluminium zirconium pentachlorohydrate and complex compounds thereof, for example with amino acids, such as glycine.
  • antiperspirants may contain typical oil-soluble and water-soluble auxiliaries in relatively small amounts.
  • Oil-soluble auxiliaries such as these include, for example,
  • the preparations according to the invention may contain the antiperspirants in quantities of 1 to 50, preferably 5 to 30 and more particularly 10 to 25% by weight, based on the solids content.
  • esterase inhibitors of component (b2) are preferably trialkyl citrates, such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and, in particular, triethyl citrate (Hydagen® CAT, Cognis GmbH, Düsseldorf, FRG). Esterase inhibitors inhibit enzyme activity and thus reduce odor formation.
  • esterase inhibitors are sterol sulfates or phosphates such as, for example, lanosterol, cholesterol, campesterol, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and esters thereof, for example glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, adipic acid, adipic acid monoethyl ester, adipic acid diethyl ester, malonic acid and malonic acid diethyl ester, hydroxycarboxylic acids and esters thereof, for example citric acid, malic acid, tartaric acid or tartaric acid diethyl ester, and zinc glycinate.
  • sterol sulfates or phosphates such as, for example, lanosterol, cholesterol, campesterol, stigmasterol and sitosterol sulfate or phosphate
  • dicarboxylic acids and esters thereof for example glutaric acid
  • the preparations according to the invention may contain the esterase inhibitors in quantities of 0.01 to 20, preferably 0.1 to 10 and more particularly 0.5 to 5% by weight, based on the solids content.
  • Suitable bactericidal or bacteriostatic agents of component (b3) are, in particular, chitosan and phenoxyethanol.
  • 5-Chloro-2-(2,4-dichlorophenoxy)-phenol which is marketed under the name of Irgasan® by Ciba-Geigy, Basle, Switzerland, has proved to be particularly effective.
  • Cosmetic deodorants counteract, mask or eliminate body odors. Body odors are formed through the action of skin bacteria on apocrine perspiration which results in the formation of unpleasant-smelling degradation products. Accordingly, deodorants contain active principles which act as germ inhibitors, enzyme inhibitors, odor absorbers or odor maskers.
  • suitable germ inhibitors are any substances which act against gram-positive bacteria such as, for example, 4-hydroxybenzoic acid and salts and esters thereof, N-(4-chlorophenyl)-N′-(3,4-dichlorophenyl)-urea, 2,4,4′-trichloro-2′-hydroxydiphenylether (triclosan), 4-chloro-3,5-dimethylphenol, 2,2′-methylene-bis-(6-bromo-4-chlorophenol), 3-methyl-4-(1 -methylethyl)-phenol, 2-benzyl-4-chlorophenol, 3-(4-chlorophenoxy)-propane-1,2-diol, 3-iodo-2-propinyl butyl carbamate, chlorhexidine, 3,4,4′-trichlorocarbanilide (TTC), antibacterial perfumes, thymol, thyme oil, eugenol, clove oil, menthol, mint oil, farnesol
  • Suitable odor absorbers are substances which are capable of absorbing and largely retaining the odor-forming compounds. They reduce the partial pressure of the individual components and thus also reduce the rate at which they spread. An important requirement in this regard is that perfumes must remain unimpaired. Odor absorbers are not active against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special perfumes of largely neutral odor known to the expert as “fixateurs” such as, for example, extracts of ladanum or styrax or certain abietic acid derivatives as their principal component. Odor maskers are perfumes or perfume oils which, besides their odor-masking function, impart their particular perfume note to the deodorants.
  • Suitable perfume oils are, for example, mixtures of natural and synthetic perfumes.
  • Natural perfumes include the extracts of blossoms, stems and leaves, fruits, fruit peel, roots, woods, herbs and grasses, needles and branches, resins and balsams.
  • Animal raw materials for example civet and beaver, may also be used.
  • Typical synthetic perfume compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • perfume compounds of the ester type are benzyl acetate, p-tert.butyl cyclohexylacetate, linalyl acetate, phenyl ethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate.
  • Ethers include, for example, benzyl ethyl ether while aldehydes include, for example, the linear alkanals containing 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxy-citronellal, lilial and bourgeonal.
  • suitable ketones are the ionones and methyl cedryl ketone.
  • Suitable alcohols are anethol, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol.
  • the hydrocarbons mainly include the terpenes and balsams. However, it is preferred to use mixtures of different perfume compounds which, together, produce an agreeable fragrance.
  • Other suitable perfume oils are essential oils of relatively low volatility which are mostly used as aroma components. Examples are sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, lime-blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil, ladanum oil and lavendin oil.
  • bergamot oil dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, ⁇ -hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, sandelice, citrus oil, mandarin oil, orange oil, allylamyl glycolate, cyclovertal, lavendin oil, clary oil, ⁇ -damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose
  • the preparations according to the invention may contain the bactericidal or bacteriostatic agents in quantities of 0.01 to 5% by weight and preferably 0.1 to 2% by weight, based on the solids content.
  • Suitable perspiration absorbers which form component (b4) are modified starch such as, for example, Dry Flo Plus (National Starch), silicates, talcum and other substances of similar modification which appear suitable for absorbing perspiration.
  • modified starch such as, for example, Dry Flo Plus (National Starch), silicates, talcum and other substances of similar modification which appear suitable for absorbing perspiration.
  • the preparations according to the invention may contain the perspiration-absorbing substances in quantities of 0.1 to 30% by weight, preferably 1 to 20% by weight and more particularly 5 to 10% by weight, based on the solids content.
  • the present invention also relates to the use of preparations of dialkyl carbonates, antiperspirants, UV filters, esterase inhibitors, bactericidal or bacteriostatic agents and/or perspiration absorbers for the production of deodorizing preparations.
  • compositions may contain components (a) and (b) in preferably the following quantities, based on the solids content:
  • formulation bases for typical ingredients, see below.
  • the most important bases include alcoholic and aqueous/alcoholic solutions, emulsions, gels, oils, wax/fat compounds, stick preparations and powders.
  • Other ingredients are superfatting agents, emulsifiers, antioxidants and perfume oils, essential oils, dyes and—for spray applications—propellent gases, such as propane and/or butane for example.
  • the preparations are preferably marketed as rollers (roll-on emulsions), sticks, deodorant or pump sprays.
  • These preparations may contain mild surfactants, pearlizing waxes, consistency factors, thickeners, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic agents, additional deodorants, film formers, solubilizers, preservatives, dyes and the like as further auxiliaries and additives.
  • Suitable surfactants are anionic, nonionic, cationic and/or amphoteric or zwitterionic surfactants which may be present in the preparations in quantities of normally about 1 to 70% by weight, preferably 5 to 50% by weight and more preferably 10 to 30% by weight.
  • anionic surfactants are soaps, alkyl benzenesulfonates, alkanesulfonates, olefin sulfonates, alkylether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfofatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, fatty acid ether sulfates, hydroxy mixed ether sulfates, monoglyceride (ether) sulfates, fatty acid amide (ether) sulfates, mono- and dialkyl sulfosuccinates, mono- and dialkyl sulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and salts thereof, fatty acid isethionates, fatty acid sarcosinate
  • anionic surfactants contain polyglycol ether chains, they may have a conventional homolog distribution although they preferably have a narrow-range homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers and mixed formals, optionally partly oxidized alk(en)yl oligoglycosides or glucuronic acid derivatives, fatty acid-N-alkyl glucamides, protein hydrolyzates (particularly wheat-based vegetable products), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
  • nonionic surfactants contain polyglycol ether chains, they may have a conventional homolog distribution, although they preferably have a narrow-range homolog distribution.
  • Typical examples of cationic surfactants are quaternary ammonium compounds, for example dimethyl distearyl ammonium chloride, and esterquats, more particularly quaternized fatty acid trialkanolamine ester salts.
  • Typical examples of amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are all known compounds.
  • surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and/or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, ⁇ -olefin sulfonates, ether carboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamidobetaines, amphoacetals and/or protein fatty acid condensates, preferably based on wheat proteins.
  • Suitable oil components are, for example, Guerbet alcohols based on fatty alcohols containing 6 to 18 and preferably 8 to 10 carbon atoms, esters of linear C 6-22 fatty acids with linear C 6-22 fatty alcohols, esters of branched C 6-13 carboxylic acids with linear C 6-22 fatty alcohols such as, for example, myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myristyl oleate, myristyl behenate, myristyl erucate, cetyl myristate, cetyl palmitate, cetyl stearate, cetyl isostearate, cetyl oleate, cetyl behenate, cetyl erucate, stearyl myristate, stearyl palmitate, stearyl stearate, stearyl isostearate, stearyl oleate, stearyl
  • esters of linear C 6-22 fatty acids with branched alcohols are particularly 2-ethyl hexanol, esters Of C 18-38 alkylhydroxycarboxylic acids with linear or branched C 6-22 fatty alcohols-(cf.
  • esters of linear and/or branched fatty acids with polyhydric alcohols for example propylene glycol, dimer diol or trimer triol
  • polyhydric alcohols for example propylene glycol, dimer diol or trimer triol
  • Guerbet alcohols triglycerides based on C 6-10 fatty acids, liquid mono-, di-and triglyceride mixtures based on C 6-18 fatty acids, esters Of C 6-22 fatty alcohols and/or Guerbet alcohols with aromatic carboxylic acids, more particularly benzoic acid, esters Of C 2-12 dicarboxylic acids with linear or branched alcohols containing 1 to 22 carbon atoms or polyols containing 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, Guerbet carbonates, esters of benzoic acid with linear and/or branched C 6-22 alcohols (for example Finsolv® TN), linear or
  • Suitable emulsifiers are, for example, nonionic surfactants from at least one of the following groups:
  • partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5,000), trimethylolpropane, pentaerythritol, sugar alcohols (for example sorbitol), alkyl glucosides (for example methyl glucoside, butyl glucoside, lauryl glucoside) and polyglucosides (for example cellulose) with saturated and/or unsaturated, linear or branched fatty acids containing 12 to 22 carbon atoms and/or hydroxycarboxylic acids containing 3 to 18 carbon atoms and adducts thereof with 1 to 30 moles of ethylene oxide;
  • block copolymers for example Polyethylene glycol-30 Dipolyhydroxystearate
  • polymer emulsifiers for example Pemulen types (TR-1, TR-2) of Goodrich;
  • ethylene oxide and/or propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known commercially available products. They are homolog mixtures of which the average degree of alkoxylation corresponds to the ratio between the quantities of ethylene oxide and/or propylene oxide and substrate with which the addition reaction is carried out.
  • C 12/18 fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known as refatting agents for cosmetic formulations from DE 20 24 051 PS.
  • Alkyl and/or alkenyl oligoglycosides are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols containing 8 to 18 carbon atoms. So far as the glycoside unit is concerned, both monoglycosides in which a cyclic sugar unit is attached to the fatty alcohol by a glycoside bond and oligomeric glycosides with a degree of oligomerization of preferably up to about 8 are suitable. The degree of oligomerization is a statistical mean value on which the homolog distribution typical of such technical products is based.
  • Typical examples of suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid monoglyceride, isostearic acid diglyceride, oleic acid monoglyceride, oleic acid diglyceride, ricinoleic acid monoglyceride, ricinoleic acid diglyceride, linoleic acid monoglyceride, linoleic acid diglyceride, linolenic acid monoglyceride, linolenic acid diglyceride, erucic acid monoglyceride, erucic acid diglyceride, tartaric acid monoglyceride, tartaric acid diglyceride, citric acid monoglyceride, citric acid diglyceride, malic acid monoglyceride, malic acid diglyceride and technical mixtures thereof which may still contain small quantities of triglyceride from the production process.
  • Suitable sorbitan esters are sorbitan monoisostearate, sorbitan sesquiisostearate, sorbitan diisostearate, sorbitan triisostearate, sorbitan monooleate, sorbitan sesquioleate, sorbitan dioleate, sorbitan trioleate, sorbitan monoerucate, sorbitan sesquierucate, sorbitan dierucate, sorbitan trierucate, sorbitan monoricinoleate, sorbitan sesquiricinoleate, sorbitan diricinoleate, sorbitan triricinoleate, sorbitan monohydroxystearate, sorbitan sesquihydroxystearate, sorbitan dihydroxystearate, sorbitan trihydroxystearate, sorbitan monotartrate, sorbitan sesquitartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate,
  • Typical examples of suitable polyglycerol esters are Polyglyceryl-2 Dipolyhydroxystearate (Dehymuls® PGPH), Polyglycerin-3-Diisostearate (Lameform® TGI), Polyglyceryl-4 Isostearate (Isolan® GI 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyceryl-3 Diisostearate (Isolan® PDI), Poly-glyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010/90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403), Polyglyceryl-2 Dip
  • polystyrene resin examples include the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, cocofatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like optionally reacted with 1 to 30 moles of ethylene oxide.
  • Suitable emulsifiers are zwitterionic surfactants.
  • Zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N,N-dimethyl ammonium glycinates, for example cocoalkyl dimethyl ammonium glycinate, N-acylaminopropyl-N,N-dimethyl ammonium glycinates, for example cocoacylaminopropyl dimethyl ammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazolines containing 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethyl hydroxyethyl carboxymethyl glycinate.
  • betaines such as the N-alkyl-N,N-dimethyl ammonium glycinates, for example cocoalkyl dimethyl ammonium glycinate, N-acylaminopropyl-N,N-dimethyl ammonium glycinates, for example cocoacylamin
  • Ampholytic surfactants are also suitable emulsifiers.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C 8/18 alkyl or acyl group, contain at least one free amino group and at least one —COOH— or —SO 3 H— group in the molecule and which are capable of forming inner salts.
  • ampholytic surfactants are N-alkyl glycines, N-alkyl propionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropyl glycines, N-alkyl taurines, N-alkyl sarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids containing around 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C 12/18 acyl sarcosine.
  • cationic surfactants are also suitable emulsifiers, those of the esterquat type, preferably methyl-quaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Typical examples of fats are glycerides, i.e. solid or liquid, vegetable or animal products which consist essentially of mixed glycerol esters of higher fatty acids.
  • Suitable waxes are inter alia natural waxes such as, for example, candelilla wax, carnauba wax, Japan wax, espartograss wax, cork wax, guaruma wax, rice oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, spermaceti, lanolin (wool wax), uropygial fat, ceresine, ozocerite (earth wax), petrolatum, paraffin waxes and microwaxes; chemically modified waxes (hard waxes) such as, for example, montan ester waxes, sasol waxes, hydrogenated jojoba waxes and synthetic waxes such as, for example, polyalkylene waxes and polyethylene glycol waxes.
  • lecithins are known among experts as glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Accordingly, lecithins are also frequently referred to by experts as phosphatidyl cholines (PCs) and correspond to the following general formula:
  • R typically represents linear aliphatic hydrocarbon radicals containing 15 to 17 carbon atoms and up to 4 cis-double bonds.
  • lecithins are the kephalins which are also known as phosphatidic acids and which are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids.
  • phospholipids are generally understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerophosphates) which are normally classed as fats. Sphingosines and sphingolipids are also suitable.
  • Suitable pearlescing waxes are, for example, alkylene glycol esters, especially ethylene glycol distearate; fatty acid alkanolamides, especially cocofatty acid diethanolamide; partial glycerides, especially stearic acid monoglyceride; esters of polybasic, optionally hydroxysubstituted carboxylic acids with fatty alcohols containing 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; fatty compounds, such as for example fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates which contain in all at least 24 carbon atoms, especially laurone and distearylether; fatty acids, such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides containing 12 to 22 carbon atoms with fatty alcohols containing 12 to 22 carbon atoms and/or polyols containing 2 to 15 carbon
  • the consistency factors mainly used are fatty alcohols or hydroxyfatty alcohols containing 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids.
  • a combination of these substances with alkyl oligoglucosides and/or fatty acid N-methyl glucamides of the same chain length and/or polyglycerol poly-12-hydroxystearates is preferably used.
  • Suitable thickeners are, for example, Aerosil® types (hydrophilic silicas), polysaccharides, more especially xanthan gum, guar-guar, agar-agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, also relatively high molecular weight polyethylene glycol monoesters and diesters of fatty acids, polyacrylates (for example Carbopols® and Pemulen types [Goodrich]; Synthalens® [Sigma]; Keltrol types [Kelco]; Sepigel types [Seppic]; Salcare types [Allied Colloids]), polyacrylamides, polyvinyl alcohol and polyvinyl pyrrolidone, surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols, for example pentaerythritol or trimethylol propane, narrow-range fatty alcohol ethoxylates or alkyl
  • Superfatting agents may be selected from such substances as, for example, lanolin and lecithin and also polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides, the fatty acid alkanolamides also serving as foam stabilizers.
  • Metal salts of fatty acids such as, for example, magnesium, aluminium and/or zinc stearate or ricinoleate may be used as stabilizers.
  • Suitable cationic polymers are, for example, cationic cellulose derivatives such as, for example, the quaternized hydroxyethyl cellulose obtainable from Amerchol under the name of Polymer JR 400®, cationic starch, copolymers of diallyl ammonium salts and acrylamides, quaternized vinyl pyrrolidone/vinyl imidazole polymers such as, for example, Luviquat® (BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides such as, for example, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen (Lamequat® L, Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers such as, for example, Amodimethicone, copolymers of adipic acid and dimethylaminohydroxypropyl diethylenetriamine (Cartaretine®, Sandoz), copolymers of acrylic acid with
  • Suitable anionic, zwitterionic, amphoteric and nonionic polymers are, for example, vinyl acetate/crotonic acid copolymers, vinyl pyrrolidone/vinyl acrylate copolymers, vinyl acetate/butyl maleate/isobornyl acrylate copolymers, methyl vinylether/maleic anhydride copolymers and esters thereof, uncrosslinked and polyol-crosslinked polyacrylic acids, acrylamidopropyl trimethylammonium chloride/acrylate copolymers, octylacrylamide methyl methacrylate/tert.-butylaminoethyl methacrylate/2-hydroxypropyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone/vinyl acetate copolymers, vinyl pyrrolidone/dimethylaminoethyl methacrylate/vinyl caprolactam terpoly
  • Suitable silicone compounds are, for example, dimethyl polysiloxanes, methylphenyl polysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and/or alkyl-modified silicone compounds which may be both liquid and resin-like at room temperature.
  • Other suitable silicone compounds are simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates.
  • biogenic agents are, for example, tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, deoxyribonucleic acid, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils, plant extracts and vitamin complexes.
  • Standard film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinyl pyrrolidone, vinyl pyrrolidone/vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid and salts thereof and similar compounds.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of compounds listed in Appendix 6, Parts A and B of the Kosmetikverowski (“Cosmetics Directive”).
  • UV protection factors in the context of the invention are, for example, organic substances (light filters) which are liquid or crystalline at room temperature and which are capable of absorbing ultraviolet radiation and of releasing the energy absorbed in the form of longer-wave radiation, for example heat.
  • UV-B filters can be oil-soluble or water-soluble. The following are examples of oil-soluble substances:
  • 4-aminobenzoic acid derivatives preferably 4-(dimethylamino)-benzoic acid-2-ethylhexyl ester, 4-(dimethylamino)-benzoic acid-2-octyl ester and 4-(dimethylamino)-benzoic acid amyl ester;
  • esters of cinnamic acid preferably 4-methoxycinnamic acid-2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester, 2-cyano-3,3-phenylcinnamic acid-2-ethylhexyl ester (Octocrylene);
  • esters of salicylic acid preferably salicylic acid-2-ethylhexyl ester, salicylic acid-4-isopropylbenzyl ester, salicylic acid homomenthyl ester;
  • esters of benzalmalonic acid preferably 4-methoxybenzalmalonic acid di-2-ethylhexyl ester
  • triazine derivatives such as, for example, 2,4,6-trianilino-(p-carbo-2′-ethyl-1′-hexyloxy)-1,3,5-triazine and Octyl Triazone as described in EP 0818450 A1or Dioctyl Butamido Triazone (Uvasorb® HEB);
  • propane-1,3-diones such as, for example, 1-(4-tert.butylphenyl)-3-(4'-methoxyphenyl)-propane-1,3-dione;
  • ketotricyclo(5.2.1.0)decane derivatives as described in EP 0694521 B1.
  • sulfonic acid derivatives of benzophenones preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and salts thereof;
  • sulfonic acid derivatives of 3-benzylidene camphor such as, for example, 4-(2-oxo-3-bornylidenemethyl)-benzene sulfonic acid and 2-methyl-5-(2-oxo-3-bornylidene)-sulfonic acid and salts thereof.
  • Typical UV-A filters are, in particular, derivatives of benzoyl methane such as, for example, 1-(4′-tert.butylphenyl)-3-(4'-methoxyphenyl)-propane-1,3-dione, 4-ter.tbutyl-4′-methoxydibenzoyl methane (Parsol 1789) or 1-phenyl-3-(4′-isopropylphenyl)-propane-1,3-dione and the enamine compounds described in DE 197 12 033 A1 (BASF).
  • the UV-A and UV-B filters may of course also be used in the form of mixtures.
  • insoluble light-blocking pigments i.e. finely dispersed metal oxides or salts
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and also oxides of iron, zirconium oxide, silicon, manganese, aluminium and cerium and mixtures thereof.
  • Silicates (talcum), barium sulfate and zinc stearate may be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics.
  • the particles should have a mean diameter of less than 100 nm, preferably between 5 and 50 nm and more preferably between 15 and 30 nm.
  • the pigments may be spherical in shape although ellipsoidal particles or other non-spherical particles may also be used.
  • the pigments may also be surface-treated, i.e. hydrophilicized or hydrophobicized.
  • Typical examples are coated titanium dioxides, for example Titandioxid T 805 (Degussa) and Eusolex® T2000 (Merck).
  • Suitable hydrophobic coating materials are, above all, silicones and, among these, especially trialkoxyoctylsilanes or dimethicones. So-called micro- or nanopigments are preferably used in sun protection products. Micronized zinc oxide is preferably used.
  • Other suitable UV filters can be found in P. Finkel's review in S ⁇ FW-Journal 122, 543 (1996) and in Par refmerie und Kosmetik 3 (1999), pages 11 et seq.
  • Secondary sun protection factors of the antioxidant type interrupt the photochemical reaction chain which is initiated when UV rays penetrate into the skin.
  • Typical examples are amino acids (for example glycine, histidine, tyrosine, tryptophane) and derivatives thereof, imidazoles (for example urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (for example anserine), carotinoids, carotenes (for example ⁇ -carotene, ⁇ -carotene, lycopene) and derivatives thereof, chlorogenic acid and derivatives thereof, liponic acid and derivatives thereof (for example dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (for example thioredoxine, glutathione, cysteine,
  • amino acids for example glycine, histidine, tyrosine, tryptophane
  • Suitable perfume oils are mixtures of natural and synthetic fragrances.
  • Natural fragrances include the extracts of blossoms (lily, lavender, rose, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, orange), roots (nutmeg, angelica, celery, cardamom, costus, iris, calmus), woods (pinewood, sandalwood, guaiac wood, cedarwood, rosewood), herbs and grasses (tarragon, lemon grass, sage, thyme), needles and branches (spruce, fir, pine, dwarf pine), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic perfume compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • perfume compounds of the ester type are benzyl acetate, phenoxyethyl isobutyrate, p-tert.butyl cyclohexylacetate, linalyl acetate, dimethyl benzyl carbinyl acetate, phenyl ethyl acetate, linalyl benzoate, benzyl formate, ethylmethyl phenyl glycinate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate.
  • Ethers include, for example, benzyl ethyl ether while aldehydes include, for example, the linear alkanals containing 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxy-citronellal, lilial and bourgeonal.
  • suitable ketones are the ionones, ⁇ -isomethylionone and methyl cedryl ketone.
  • Suitable alcohols are anethol, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol.
  • the hydrocarbons mainly include the terpenes and balsams. However, it is preferred to use mixtures of different perfume compounds which, together, produce an agreeable fragrance.
  • Other suitable perfume oils are essential oils of relatively low volatility which are mostly used as aroma components. Examples are sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, lime-blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil, ladanum oil and lavendin oil.
  • bergamot oil dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, ⁇ -hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, sandelice, citrus oil, mandarin oil, orange oil, allylamyl glycolate, cyclovertal, lavendin oil, clary oil, ⁇ -damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose
  • Suitable dyes are any of the substances suitable and approved for cosmetic purposes as listed, for example, in the publication “Kosmetician Anlagenrbesch” of the Farbstoffkommission der Deutschen Deutschen Deutschen Deutschen Anlagenstechnik, Verlag Chemie, Weinheim, 1984, pages 81 to 106. These dyes are normally used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total percentage content of auxiliaries and additives may be from 1 to 50% by weight and is preferably from 5 to 40% by weight, based on the particular formulation.
  • the formulations may be produced by standard hot or cold processes and are preferably produced by the phase inversion temperature method.
  • compositions 1 to 4 correspond to the invention, formulation C1 is intended for comparison.
  • compositions 1 to 4 correspond to the invention, formulations C1 and C2 are intended for comparison.
  • the results are set out in Table 3.
US10/181,641 2000-01-21 2001-01-12 Deodorizing preparations Abandoned US20030053970A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/202,990 US8765104B2 (en) 2000-01-21 2008-09-02 Deodorizing preparations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10002643.5 2000-01-21
DE10002643A DE10002643A1 (de) 2000-01-21 2000-01-21 Desodorierende Zubereitungen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/202,990 Continuation US8765104B2 (en) 2000-01-21 2008-09-02 Deodorizing preparations

Publications (1)

Publication Number Publication Date
US20030053970A1 true US20030053970A1 (en) 2003-03-20

Family

ID=7628360

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/181,641 Abandoned US20030053970A1 (en) 2000-01-21 2001-01-12 Deodorizing preparations
US12/202,990 Expired - Lifetime US8765104B2 (en) 2000-01-21 2008-09-02 Deodorizing preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/202,990 Expired - Lifetime US8765104B2 (en) 2000-01-21 2008-09-02 Deodorizing preparations

Country Status (6)

Country Link
US (2) US20030053970A1 (de)
EP (4) EP1338267B1 (de)
JP (1) JP4911851B2 (de)
DE (4) DE10002643A1 (de)
ES (3) ES2231742T3 (de)
WO (1) WO2001052806A1 (de)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040028614A1 (en) * 2000-07-07 2004-02-12 Alberto Corbella Aerosols
US20040234563A1 (en) * 2001-07-27 2004-11-25 Stefan Bruening Emulsifier mixture
US20040234561A1 (en) * 2001-07-13 2004-11-25 Achim Ansmann Wax-based compositions
WO2005063189A1 (de) * 2003-12-23 2005-07-14 Beiersdorf Ag Wasserfreie und silikonölfreie deodorant- oder antitranspirantformulierung in stiftform
US20050238598A1 (en) * 2004-04-07 2005-10-27 Lionnel Aubert Antiperspirant compositions and method comprising wax microparticles
US20050255064A1 (en) * 2001-12-17 2005-11-17 Stefan Bruening Antiperspirant composition
US20060188551A1 (en) * 2003-01-08 2006-08-24 Matthias Hauser Products comprising a sheet and a wax dispersion
EP1701692A1 (de) * 2003-12-23 2006-09-20 Beiesrdorf Ag Wasserfreie und silikon lfreie deodorant- oder antitranspirantformulierung in aerosolform
US20070178053A1 (en) * 2006-01-27 2007-08-02 Conopco Inc, D/B/A Unilever Antiperspirant compositions
US20090087396A1 (en) * 2004-04-22 2009-04-02 Coty B.V. Sweat-Absorbing Cosmetic Product and Method for the Production Thereof
US20090092568A1 (en) * 2007-10-03 2009-04-09 Zorbx Inc. Deodorizing composition and method of forming thereof
US20090220555A1 (en) * 2004-04-22 2009-09-03 Coty B.V. Sweat-Absorbing Cosmetic Product and Method for the Production Thereof
DE102008052747A1 (de) 2008-10-22 2010-04-29 Beiersdorf Ag Antitranspirantstift ohne flüchtige Trägeröle
US20110070183A1 (en) * 2009-09-24 2011-03-24 Evonik Goldschmidt Gmbh Crosslinked polysiloxanes, a process for their preparation and use of the crosslinked polysiloxanes in emulsifier systems for water-in-oil emulsions
EP2374835A2 (de) 2010-04-07 2011-10-12 Evonik Goldschmidt GmbH Polyamid-1010-Pulver und dessen Verwendung in Körperpflegeprodukten
US9554981B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
EP3209387B1 (de) 2014-10-24 2019-04-24 Henkel AG & Co. KGaA Verwendung von chitosanen in schweisshemmenden kosmetische mitteln, welche frei sind von halogeniden und/oder hydroxyhalogeniden von aluminium und/oder zirconiu

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030049218A1 (en) * 2001-08-28 2003-03-13 Amit Patel Antiperspirant deodorant emulsion
DE10162049A1 (de) * 2001-12-17 2003-06-26 Cognis Deutschland Gmbh Antitranspirant-Zusammensetzung
DE10323703A1 (de) * 2003-05-22 2004-12-23 Beiersdorf Ag Mikrobizide Zubereitungen und ihre Verwendung
DE102006062433A1 (de) * 2006-12-27 2008-07-03 Henkel Kgaa Antitranspirant- und Deodorant-Zusammensetzungen mit verringertem Reizpotenzial
ES2950993T3 (es) 2008-11-17 2023-10-17 Oreal Procedimiento cosmético para tratar la transpiración humana utilizando partículas de un material mineral amorfo expandido; composiciones
WO2012064557A2 (en) * 2010-11-08 2012-05-18 Lipo Chemicals Inc. Deodorizing compositions
JP5930647B2 (ja) * 2011-09-30 2016-06-08 株式会社マンダム 乳化型制汗化粧料
WO2015135701A1 (en) 2014-03-12 2015-09-17 Basf Se Carbonates of alcohol alkoxylates as adjuvants for crop protection
EP3777534A1 (de) * 2014-03-26 2021-02-17 The Brigham & Women's Hospital, Inc. Zusammensetzungen und verfahren zur ex-vivo-vermehrung von menschlichen hämatopoietischen stamm-/vorläuferzellen
DE102014222270A1 (de) * 2014-10-31 2016-05-04 Thomas Brunner Hygiene GmbH Kosmetische Antitranspirant-Zusammensetzung
WO2019069209A1 (en) 2017-10-02 2019-04-11 Tbf Environmental Technology Inc. SOLVENT COMPOUNDS FOR USE AS AGENTS OF COALESCENCE

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861147A (en) * 1997-06-09 1999-01-19 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume
US5968488A (en) * 1996-10-21 1999-10-19 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors
US6045785A (en) * 1996-10-17 2000-04-04 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations
US6280712B1 (en) * 1997-08-29 2001-08-28 Cognis Deutschland Gmbh Sun screen agents
US6316030B1 (en) * 1998-10-14 2001-11-13 Cognis Deutschland Gmbh Use of nanoscale sterols and sterol esters
US6368577B1 (en) * 1998-12-11 2002-04-09 Cognis Deutschland Gmbh Nanoscale organic UV filters
US6428776B1 (en) * 1997-11-11 2002-08-06 Cognis Deutschland Gmbh Aqueous cosmetic preparations in stick form
US6482418B1 (en) * 1996-06-12 2002-11-19 Henkel Kommanditgesellschaft Auf Aktien Cosmetic and/or pharmaceutical preparations comprising dialkenyl carbonates
US6497863B1 (en) * 1999-04-20 2002-12-24 Biotec Pharmacon Asa Deodorizing preparations
US20030059385A1 (en) * 1999-12-24 2003-03-27 Achim Ansmann Use of nano-scale deodorants
US6620409B2 (en) * 1999-12-24 2003-09-16 Henkel Kommanditgesellschaft Auf Aktien Hair and skin care agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2524110A1 (de) * 1974-06-12 1976-01-02 Colgate Palmolive Co Aerosol-antitranspirant
US5284649A (en) * 1992-09-29 1994-02-08 The Procter & Gamble Company Deodorant gel sticks containing 1-hydroxy pyridinethione active
US5830487A (en) 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
WO1995016824A1 (en) 1993-12-13 1995-06-22 The Procter & Gamble Company Lotion composition for imparting soft, lubricious feel to tissue paper
MX9606375A (es) 1994-06-17 1997-03-29 Procter & Gamble Composicion de locion mejorada para el tratamiento de papel higienico.
AUPM632494A0 (en) 1994-06-21 1994-07-14 Biocom Pty Ltd Auxiliary injector
US5665426A (en) 1995-02-06 1997-09-09 Kimberly-Clark Corporation Soft treated tissue
DE19540296C2 (de) * 1995-10-28 1998-01-29 Henkel Kgaa Desodorierende Zubereitungen
NZ328102A (en) * 1996-06-24 1998-04-27 Givaudan Roure Int Fragrance precursors and deodorant compositions
JPH11106326A (ja) 1997-09-30 1999-04-20 Nikko Chemical Co Ltd 炭酸ジエステルを含有する外用剤又は化粧料
JPH11246378A (ja) * 1998-02-27 1999-09-14 Lion Corp 非水系粉末エアゾール型制汗剤組成物
JP4329914B2 (ja) * 1998-06-26 2009-09-09 三省製薬株式会社 制汗剤
DE19858812A1 (de) * 1998-12-21 2000-06-29 Cognis Deutschland Gmbh Desodorierende kosmetische Mittel
US6153209A (en) 1999-09-28 2000-11-28 The Procter & Gamble Company Article having a transferable breathable skin care composition thereon

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482418B1 (en) * 1996-06-12 2002-11-19 Henkel Kommanditgesellschaft Auf Aktien Cosmetic and/or pharmaceutical preparations comprising dialkenyl carbonates
US6045785A (en) * 1996-10-17 2000-04-04 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations
US5968488A (en) * 1996-10-21 1999-10-19 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors
US5861147A (en) * 1997-06-09 1999-01-19 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume
US6280712B1 (en) * 1997-08-29 2001-08-28 Cognis Deutschland Gmbh Sun screen agents
US6428776B1 (en) * 1997-11-11 2002-08-06 Cognis Deutschland Gmbh Aqueous cosmetic preparations in stick form
US6316030B1 (en) * 1998-10-14 2001-11-13 Cognis Deutschland Gmbh Use of nanoscale sterols and sterol esters
US6368577B1 (en) * 1998-12-11 2002-04-09 Cognis Deutschland Gmbh Nanoscale organic UV filters
US6497863B1 (en) * 1999-04-20 2002-12-24 Biotec Pharmacon Asa Deodorizing preparations
US20030059385A1 (en) * 1999-12-24 2003-03-27 Achim Ansmann Use of nano-scale deodorants
US6620409B2 (en) * 1999-12-24 2003-09-16 Henkel Kommanditgesellschaft Auf Aktien Hair and skin care agents

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040028614A1 (en) * 2000-07-07 2004-02-12 Alberto Corbella Aerosols
US7427406B2 (en) 2000-07-07 2008-09-23 Cognis Deutschland Gmbh & Co. Kg Aerosols
US20040234561A1 (en) * 2001-07-13 2004-11-25 Achim Ansmann Wax-based compositions
US8716336B2 (en) 2001-07-13 2014-05-06 Cognis Ip Management Gmbh Smooth-feeling wax-based compositions for personal care preparations
US20080166431A1 (en) * 2001-07-13 2008-07-10 Achim Ansmann Smooth-Feeling Wax-Based Compositions for Personal Care Preparations
US7799333B2 (en) 2001-07-27 2010-09-21 Cognis Ip Management Gmbh Emulsifier mixture containing fatty alcohols, ethoxylated fatty alcohols and oil and wax components
US20040234563A1 (en) * 2001-07-27 2004-11-25 Stefan Bruening Emulsifier mixture
US20050255064A1 (en) * 2001-12-17 2005-11-17 Stefan Bruening Antiperspirant composition
US20060188551A1 (en) * 2003-01-08 2006-08-24 Matthias Hauser Products comprising a sheet and a wax dispersion
WO2005063189A1 (de) * 2003-12-23 2005-07-14 Beiersdorf Ag Wasserfreie und silikonölfreie deodorant- oder antitranspirantformulierung in stiftform
EP1701692A1 (de) * 2003-12-23 2006-09-20 Beiesrdorf Ag Wasserfreie und silikon lfreie deodorant- oder antitranspirantformulierung in aerosolform
US20050238598A1 (en) * 2004-04-07 2005-10-27 Lionnel Aubert Antiperspirant compositions and method comprising wax microparticles
US8900609B2 (en) 2004-04-22 2014-12-02 Coty B.V. Sweat-absorbing cosmetic product and method for the production thereof
US20090220555A1 (en) * 2004-04-22 2009-09-03 Coty B.V. Sweat-Absorbing Cosmetic Product and Method for the Production Thereof
US20090087396A1 (en) * 2004-04-22 2009-04-02 Coty B.V. Sweat-Absorbing Cosmetic Product and Method for the Production Thereof
US20070178053A1 (en) * 2006-01-27 2007-08-02 Conopco Inc, D/B/A Unilever Antiperspirant compositions
WO2007085299A1 (en) * 2006-01-27 2007-08-02 Unilever Plc Antiperspirant compositions
RU2447880C2 (ru) * 2006-01-27 2012-04-20 Унилевер Нв Композиции антиперспиранта
US8318806B2 (en) * 2007-10-03 2012-11-27 Zorbx Inc. Deodorizing composition and method of forming thereof
US20090092568A1 (en) * 2007-10-03 2009-04-09 Zorbx Inc. Deodorizing composition and method of forming thereof
DE102008052747A1 (de) 2008-10-22 2010-04-29 Beiersdorf Ag Antitranspirantstift ohne flüchtige Trägeröle
EP2301987A1 (de) 2009-09-24 2011-03-30 Evonik Goldschmidt GmbH Vernetzte Polysiloxane, Verfahren zu deren Herstellung und Verwendung von vernetzten Polysiloxanen in Emulgatorsystemen für Wasser-in-Öl-Emulsionen
US8470306B2 (en) 2009-09-24 2013-06-25 Evonik Goldschmidt Gmbh Crosslinked polysiloxanes, a process for their preparation and use of the crosslinked polysiloxanes in emulsifier systems for water-in-oil emulsions
US20110070183A1 (en) * 2009-09-24 2011-03-24 Evonik Goldschmidt Gmbh Crosslinked polysiloxanes, a process for their preparation and use of the crosslinked polysiloxanes in emulsifier systems for water-in-oil emulsions
EP2374835A2 (de) 2010-04-07 2011-10-12 Evonik Goldschmidt GmbH Polyamid-1010-Pulver und dessen Verwendung in Körperpflegeprodukten
US9554981B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9554982B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076490B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076489B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076474B2 (en) 2014-03-13 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
EP3209387B1 (de) 2014-10-24 2019-04-24 Henkel AG & Co. KGaA Verwendung von chitosanen in schweisshemmenden kosmetische mitteln, welche frei sind von halogeniden und/oder hydroxyhalogeniden von aluminium und/oder zirconiu

Also Published As

Publication number Publication date
ES2235123T3 (es) 2005-07-01
DE10002643A1 (de) 2001-07-26
ES2233889T3 (es) 2005-06-16
DE50104433D1 (de) 2004-12-09
EP1338266A1 (de) 2003-08-27
US20080317694A1 (en) 2008-12-25
JP2003525877A (ja) 2003-09-02
JP4911851B2 (ja) 2012-04-04
WO2001052806A1 (de) 2001-07-26
EP1338267B1 (de) 2004-12-08
ES2231742T3 (es) 2005-05-16
EP1338267A1 (de) 2003-08-27
DE50104720D1 (de) 2005-01-05
EP1338266B1 (de) 2004-11-03
US8765104B2 (en) 2014-07-01
EP1338268A1 (de) 2003-08-27
DE50104789D1 (de) 2005-01-13
EP1338268B1 (de) 2004-12-01
EP1248592A1 (de) 2002-10-16

Similar Documents

Publication Publication Date Title
US8765104B2 (en) Deodorizing preparations
US7176171B2 (en) Low-viscosity opacifiers without anionic surface-active agents
US6828452B2 (en) Method for producing acyl amino acids
US7268107B2 (en) Highly concentrated, free-flowing pearly lustre concentrates
US6916465B2 (en) Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives
US7427406B2 (en) Aerosols
US20030044469A1 (en) Skincare agents
US20050019353A1 (en) Emollients and cosmetic compositions
US20070128144A1 (en) Opacifiers
US6927241B2 (en) Emulsifiers
US20050000390A1 (en) Low-viscosity opacifiers free from anionic surface-active agents
US20060008482A1 (en) Oil phases for cosmetic agents
US20030186934A1 (en) Use of inulins and inulin derivatives
US8080586B2 (en) Self-emulsifying preparations
US7279456B2 (en) Surfactant mixtures
US20040044078A1 (en) Cosmetic and/or pharmaceutical emulsions
US20040043045A1 (en) Use of fatty alcohols as solubilizing agents
US20020010114A1 (en) Water-based cleansing compositions
US20050112156A1 (en) Sun protection compositions
US20040028742A1 (en) Thickening agent
US7572435B2 (en) Oil bodies for cosmetic compositions containing cyclohexyl cyclohexane
US20030147963A1 (en) Cosmetic preparations
US20040146478A1 (en) Use of cationic preparations
US20050089497A1 (en) Emollients and cosmetic compositions
US6914146B2 (en) Methods of using esterquats having acyl groups derived from short-chain monocarboxylic acids and short-chain dicarboxylic acids to improve cosmetic compositions

Legal Events

Date Code Title Description
AS Assignment

Owner name: COGNIS DEUTSCHLAND GMBH & CO. KG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRUENING, STEFAN;GONDEK, HELGA;ANSMANN, ACHIM;REEL/FRAME:013253/0197;SIGNING DATES FROM 20020708 TO 20020710

AS Assignment

Owner name: COGNIS IP MANAGEMENT GMBH, GERMANY

Free format text: PATENT AND TRADEMARK TRANSFER AND LICENSE AGREEMENT;ASSIGNOR:COGNIS DEUTSCHLAND GMBH & CO. KG;REEL/FRAME:021805/0578

Effective date: 20041231

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION